Armistice Capital, LLC Portfolio Holdings

Armistice Capital, LLC

  • $5.71 Billion
  • Q2 2025

Armistice Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $5.71 Billion distributed in 210 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $231M, Supernus Pharmaceuticals, Inc. with a value of $152M, Immunovant, Inc. with a value of $143M, Travere Therapeutics, Inc. with a value of $131M, and Incyte Corp with a value of $91M.

Examining the 13F form we can see an decrease of $851M in the current position value, from $6.56B to 5.71B.

Armistice Capital, LLC is based out at New York, NY

Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $5.71 Billion
ETFs: $3.02 Billion
Healthcare: $1.87 Billion
Technology: $329 Million
Consumer Cyclical: $329 Million
Consumer Defensive: $85.6 Million
Communication Services: $38.9 Million
Basic Materials: $14.5 Million
Industrials: $11.9 Million
Other: $9.21 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.26T
$48.1 Million 0.84% of portfolio
219,423
Q2 2025 Reduced 16.92%
$222B
$41.9 Million 0.73% of portfolio
143,580
Q2 2025 Added 258.95%
$3.95T
$41.7 Million 0.73% of portfolio
83,737
Q2 2025 Reduced 36.56%
$1.21T
$33.6 Million 0.59% of portfolio
190,400
Q2 2025 Reduced 35.89%
$452B
$11.5 Million 0.2% of portfolio
75,218
Q2 2025 New
$456B
$9.8 Million 0.17% of portfolio
62,000
Q2 2025 Reduced 41.57%
$1.27T
$9.29 Million 0.16% of portfolio
41,000
Q2 2025 Reduced 33.87%
$324B
$6.58 Million 0.12% of portfolio
58,000
Q2 2025 New
$233B
$3.28 Million 0.06% of portfolio
47,000
Q2 2025 Added 95.83%
$608B
$3.04 Million 0.05% of portfolio
3,898
Q2 2025 Added 1,137.46%
$1.78T
$1.97 Million 0.03% of portfolio
2,675
Q2 2025 New
$306B
$503,000 0.01% of portfolio
1,958
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 210
  • Current Value $5.71 Billion
  • Prior Value $6.56 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 62 stocks
  • Additional Purchases 39 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 74 stocks
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email